Pfizer: Undervalued Safe Haven In Risk-Off Market​

Since my last coverage , Pfizer (NYSE: PFE ) has remained relatively stable, while the S&P 500 declined by 2.25%, a reflection of its defensive attractiveness in a risk-off environment. Its bull case is centered in its core pharma growth, expanding beyond pandemicYiannis Zourmpanos, founder of Yiazou IQ, an AI-driven stock research platform providing all-in-one stock reports. Experience: Previously worked at Deloitte and KPMG in external/internal auditing and consulting. Education: Chartered Certified Accou ...